发明名称 Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease
摘要 A FcgammaRIIa transgenic non-human animal model for autoimmune disease, particularly arthritis. This invention also provides a method of using this model to screen compounds that can reduce aberrant immune activity including aberrant immune complex formation aberrant immune complex clearance and immune complex induced inflammation. This invention also provides means of using this model to treat or prevent autoimmune disease.
申请公布号 NZ536963(A) 申请公布日期 2008.04.30
申请号 NZ20030536963 申请日期 2003.06.06
申请人 TRILLIUM THERAPEUTICS INC 发明人 HOGARTH, PHILLIP MARK;MOTTRAM, PATRICIA LESLEY;SARDJONO, CAROLINE TAN
分类号 A01K67/027;A61K45/00;A61P1/04;A61P19/02;A61P29/00;A61P37/02;A61P43/00;C07K14/735;C12N15/09;C12N15/12;C12N15/85;C12Q1/02;G01N33/15;G01N33/50;(IPC1-7):C12N15/85;C07K14/705 主分类号 A01K67/027
代理机构 代理人
主权项
地址